Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the uael domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/imagionbx/wp-includes/functions.php on line 6114

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the kirki domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/imagionbx/wp-includes/functions.php on line 6114
MagSense® Applications & Pipeline | Imagion Biosystems
Search
Twitter-square Facebook-square Linkedin Youtube

MagSense® Applications & Pipeline

Molecularly targeted magnetism

MagSense® Clinical Pipeline

MagSense® products are disruptive – enabling molecular MRI for primary diagnosis & and staging, stand-alone diagnostics, and companion diagnostics.

Clinical Imaging

MagSense® HER2 Imaging Agent (MSH2IA)

MagSense® FR Imaging Agent (MSFIA)

MagSense® PSMA Imaging Agent (MSPIA)

Vascular Imaging Agent

Pancreatic
Cancer

DiscoveryPreclinical DevelopmentClinical Development
Phase 1 Complete
IND-enabling Nominee
In vivo PoC complete
In vivo PoC complete
Prestige Biopharma

Other Biomedical Applications

Hyperthermic
Tumor Ablation

Nanoparticle-based
Vaccines

Phase 1 on-going
Pre-commercial Supply
DiscoveryPreclinical DevelopmentClinical Development

Clinical Imaging

MagSense® HER2 Imaging Agent (MSH2IA)

Phase 1 Complete

MagSense® FR Imaging Agent (MSFIA)

IND-enabling Nominee

MagSense® PSMA Imaging Agent (MSPIA)

In vivo PoC complete

ContraMax® Vascular Imaging

In vivo PoC complete

Pancreatic Cancer

Prestiege Biopharma

Other Biomedical Applications

Hyperthermic Tumor Ablation

Phase 1 on-going

Nanoparticle-based Vaccines

Pre-commercial Supply
Visit MagSense® HER2 Clinical Trial

Disrupting Diagnostic Imaging

MagSense® technology enables a new era in functional imaging, promising more sensitivity and safer detection of cancers and other critical diseases. Specialized bio-safe magnetic nanoparticles are coated with tumor-targeting molecules that are able to circulate through normal blood flow or local injection. When bound to a tumor the MagSense® particles can then be detected by Magnetic Resonance Imaging scanners.
Learn more about MagSense®

MagSense® Pre-Clinical and Clinical Applications

Transforming precision medicine to make better-informed decisions for patients’ diagnosis and treatment.

Learn more about our partnerships

If you’re looking to become a strategic partner to help design and drive clinical development, learn more about our collaboration opportunities.

Strategic Partnerships

About Imagion Biosystems

Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.

Contact us

Join our email list

Stay informed about our latest news and developments.

© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance

Twitter-square Facebook-square Linkedin Youtube